Genmab — Juni 2013
-
Giver den ikke milestone ved opstart af phase III ?
-
Arzerra blockbuster også i Autoimmun
-
vi får update i år på Autoimmun
-
GSK kommer med AU update senere i år
-
GSK indsender ansøgning indenfor et par måneder
-
208
-
det ligger godt til de ældre....
-
ikke flere informationer om faseIII end der var i meddelelsen
-
h2h kommer snart i 2104
-
the market is to grow substantially for Arzerra the next year
-
så er der Dara
-
Breakthorugh og fast track
-
broad and fast development plan
-
zero cost and limited risk
-
Programmet omfatter alle versioner af MM
-
programmet bliver mere detaljeret i løbet af i år
-
data skal ses i lyset af at patienterne havde været så meget igennem
-
behandlingerne inden dara:
5,2 i gennemsnit
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind